142 related articles for article (PubMed ID: 7690616)
1. [Clinical trials of recombinant gamma-interferon. Circulating interferon and the 2,5-oligoadenylate synthetase activity after intramuscular and inhalation administrations].
Sokolova TM; Lopatina OA; Nosik NN; Cheshik SG
Biull Eksp Biol Med; 1993 Jun; 115(6):633-4. PubMed ID: 7690616
[TBL] [Abstract][Full Text] [Related]
2. [Interferon status and the activity of dsRNA-dependent enzymes in volunteers and influenza patients receiving human recombinant alpha 2-interferon (reaferon)].
Lavrukhina LA; Sokolova TM; Suetina IA; Kniazeva LD; Mironova LL
Vopr Virusol; 1988; 33(5):580-5. PubMed ID: 2464241
[TBL] [Abstract][Full Text] [Related]
3. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of 2,5-oligoadenylate synthetase and protein kinase activities in clinical studies of larifan and recombinant interferon alpha in volunteers].
Sokolova TM; Nosik NN; Lopatina OA; Krylov VF
Antibiot Khimioter; 1991 Jul; 36(7):42-5. PubMed ID: 1953190
[TBL] [Abstract][Full Text] [Related]
5. [The effect of different types of recombinant interferon on the induction of 2,5-oligoadenylate synthetase in natural killers and the tumor cells in bladder cancer patients].
Vozianov AF; Drannik GN; Verkhatskaia AA; Zavelevich MP; Prokhnevskaia EL; Verkhatskiĭ PP; Klimenko IA
Urol Nefrol (Mosk); 1993; (5):22-5. PubMed ID: 7508649
[TBL] [Abstract][Full Text] [Related]
6. Determination of 2'-5'-oligoadenylate synthetase in serum and peripheral blood mononuclear cells before and after subcutaneous application of recombinant interferon beta and gamma.
Bruchelt G; Fierlbeck G; Schiebel U; Bogenschütz O; Rassner G; Niethammer D
Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):521-8. PubMed ID: 1457613
[TBL] [Abstract][Full Text] [Related]
7. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
[TBL] [Abstract][Full Text] [Related]
8. Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
Perino LJ; Short EC; Burge LJ; Winter DA; Fulton RW
Am J Vet Res; 1990 Jun; 51(6):886-92. PubMed ID: 1695068
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of interferon treatment in patients with renal cell carcinoma and bladder carcinoma by oligo-A synthetase assay and determination of immunological parameters.
Grups JW; Komprecht B
J Biol Regul Homeost Agents; 1989; 3(3):98-101. PubMed ID: 2516404
[TBL] [Abstract][Full Text] [Related]
10. Induction of 2'-5' oligoadenylate synthetase during interferon treatment of chronic myelogenous leukemia.
Moritz T; Weissmann B; Grünewald B; Hust H; Kummer G; Niederle N
Mol Biother; 1992 Jun; 4(2):97-102. PubMed ID: 1381190
[TBL] [Abstract][Full Text] [Related]
11. Activation of 2',5'-oligoadenylate synthetase and B-2 microglobulin in cancer patients treated with partially pure gamma interferon: dependence of biological effect on administration route.
Rosenblum MG; Riso A; Gutterman JU
Cancer Chemother Pharmacol; 1986; 16(3):273-6. PubMed ID: 3084109
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers.
Salmon P; Le Cotonnec JY; Galazka A; Abdul-Ahad A; Darragh A
J Interferon Cytokine Res; 1996 Oct; 16(10):759-64. PubMed ID: 8910759
[TBL] [Abstract][Full Text] [Related]
13. Biologic response (antiviral) to recombinant human interferon alpha 2a as a function of dose and route of administration in healthy volunteers.
Witter F; Barouki F; Griffin D; Nadler P; Woods A; Wood D; Lietman P
Clin Pharmacol Ther; 1987 Nov; 42(5):567-75. PubMed ID: 2445516
[TBL] [Abstract][Full Text] [Related]
14. Enzyme markers for the presence of circulating interferon: 2-5A synthetase in blood lymphocytes and protein kinase in platelet-rich plasma.
Buffet-Janvresse C; Hovanessian AG
Proc Soc Exp Biol Med; 1984 Feb; 175(2):169-75. PubMed ID: 6198652
[TBL] [Abstract][Full Text] [Related]
15. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
[TBL] [Abstract][Full Text] [Related]
16. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
[TBL] [Abstract][Full Text] [Related]
17. A bioassay for serum interferon based on induction of 2'5'-oligoadenylate synthetase activity.
Uno K; Sato T; Takada Y; Fujioka K; Suginoshita Y; Kakimi K; Moriyasu F; Kishida T
J Interferon Cytokine Res; 1998 Dec; 18(12):1011-8. PubMed ID: 9877443
[TBL] [Abstract][Full Text] [Related]
18. Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine.
Goldstein D; Sielaff KM; Storer BE; Brown RR; Datta SP; Witt PL; Teitelbaum AP; Smalley RV; Borden EC
J Natl Cancer Inst; 1989 Jul; 81(14):1061-8. PubMed ID: 2472488
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
[TBL] [Abstract][Full Text] [Related]
20. [Enzyme activity of interferon system in virus diseases].
Sokolova TM; Suetina IA; Nosik NN; Krylov VF
Biull Eksp Biol Med; 1991 May; 111(5):515-6. PubMed ID: 1715215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
